US 10722487
Glutaminase inhibitor therapy
granted A61KA61K31/282A61K31/337
Quick answer
US patent 10722487 (Glutaminase inhibitor therapy) held by The Board of Regents of the University of Texas System expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/282, A61K31/337, A61K31/4196, A61K31/433